Hospital Costa Del Sol-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2022

  1. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction

    Medicina Clinica, Vol. 159, Núm. 4, pp. 164-170

  2. The EPICTER score: a bedside and easy tool to predict mortality at 6 months in acute heart failure

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2348-2356

2021

  1. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  2. Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 283.e9-283.e16

  3. Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry

    International Journal of Cardiology, Vol. 332, pp. 29-34

  4. Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study)

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 1

2019

  1. Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients

    HIV Medicine, Vol. 20, Núm. 6, pp. 359-367

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  2. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494

  3. Prognostic implication of early ventricular fibrillation among patients with ST elevation myocardial infarction

    Coronary Artery Disease, Vol. 28, Núm. 7, pp. 570-576

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2014

  1. Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort

    International Journal of Infectious Diseases, Vol. 26, pp. 83-87

2013

  1. Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 472-478

  2. Medida de la presión arterial en consulta y automatizada (BPTru®) para evaluar el efecto de bata blanca

    Medicina Clinica, Vol. 138, Núm. 14, pp. 597-601

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  3. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

2010

  1. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals

    Clinical Microbiology and Infection, Vol. 16, Núm. 9, pp. 1408-1413

2006

  1. Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM

    Medicina Intensiva, Vol. 30, Núm. 9, pp. 432-439